Related Experiment Videos
Can cellular transplantation improve function in doxorubicin-induced heart failure?
M Scorsin1, A A Hagege, I Dolizy
1Department of Cardiovascular Surgery, INSERM U-127, Paris, France.
Circulation
|December 16, 1998
Summary
Fetal cardiomyocyte transplantation improved function in globally failing hearts. The benefits may stem from released factors, not necessarily the sustained presence of transplanted cells.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Cell Therapy
Background:
- Fetal cardiomyocyte transplantation shows promise for regionally infarcted myocardium.
- Its efficacy in global heart failure remains largely unexplored.
Purpose of the Study:
- To investigate the effects of fetal cardiomyocyte transplantation on global heart failure in a mouse model.
- To assess the impact on left ventricular function and explore potential mechanisms.
Main Methods:
- Doxorubicin-induced heart failure in female mice.
- Intramyocardial injection of fetal cardiomyocytes or culture medium.
- Echocardiographic assessment of left ventricular function at baseline, 2 weeks, and 1 month post-transplantation.
Main Results:
- Cell-treated mice showed significant improvement in fractional shortening at 2 weeks and 1 month post-transplantation.
- Control and sham groups did not exhibit significant functional improvements.
- Transplanted cells were largely undetectable, suggesting indirect mechanisms of action.
Conclusions:
- Cellular transplantation can enhance the function of globally failing hearts.
- The therapeutic effect may be mediated by secreted cardioprotective factors rather than cell engraftment.
- This suggests a paracrine mechanism for cell-based cardiac repair.